| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |